MediPal Holdings Corporation (TYO:7459)

MediPal Holdings Revenue

MediPal Holdings had revenue of 989.50B JPY in the quarter ending June 30, 2026, with 4.69% growth. This brings the company's total for the last twelve months to 3.86T, up 4.17% year-over-year. In the fiscal year ending March 31, 2026, MediPal Holdings had annual revenue of 3.82T with 3.98% growth. That makes MediPal Holdings the 603rd largest company in the world by revenue and 50th in Japan.

• Revenue (ttm): 3.86T
• Revenue Growth: +4.17%
• P/S Ratio: 0.17
• Revenue / Employee: 296.51M
• Employees: 13,024
• Market Cap: 695.16B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Wholesale Business of Medical Pharmaceuticals and Related Products 2.47T 64.5%
• Cosmetics, Daily Necessities, and Over-The-Counter Pharmaceutical Wholesale Business 1.24T 32.4%
• Businesses Related to the Wholesale of Veterinary Drugs and Raw Materials for Food Processing 117.33B 3.1%

Fiscal year ended Mar 31, 2026 See the full MediPal Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.82T	146.03B	3.98%
Mar 31, 2025	3.67T	112.60B	3.16%
Mar 31, 2024	3.56T	198.72B	5.91%
Mar 31, 2023	3.36T	69.09B	2.10%
Mar 31, 2022	3.29T	79.80B	2.48%

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error